The Aug. 15 edition of the journal Science features a major article about the most important problem in obstetrics: preterm labor. The article, "Preterm labor: one syndrome, many causes," delivers a powerful message: preterm ...
Aug 15, 2014
0
0
(Medical Xpress)—The hormone progesterone could become part of therapy against the most aggressive form of brain cancer. High concentrations of progesterone kill glioblastoma cells and inhibit tumor growth when the tumors ...
Jun 19, 2014
0
0
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found new targets for potential intervention in breast cancer. These new targets could eventually increase effectiveness and reduce the undesirable ...
Jun 5, 2014
0
0
Identification of a new pregnancy-supporting hormone in horses has resolved a reproductive mystery that has puzzled scientists for decades, and it may have important implications for sustaining human pregnancies, reports ...
Feb 26, 2014
0
16
New research findings may soon help doctors personalize preterm birth prevention treatments by identifying which women at higher risk for preterm birth will be helped by progesterone injections.
Feb 3, 2014
0
0
Treatment with progesterone, a naturally occurring hormone that has been shown to alleviate severe hot flashes and night sweats in post-menopausal women, poses little or no cardiovascular risk, according to a new study by ...
Jan 15, 2014
0
0
How well a woman recovers from a concussion may depend on that time of the month.
Nov 13, 2013
1
0
(Medical Xpress)—Tremendous progress has been made in understanding how uterine fibroid tumors—the most common tumor in women – start and grow. A new paper in the New England Journal of Medicine synthesizes the latest ...
Oct 14, 2013
0
0
In a new paper in Cancer Cell, a team led by Judy Lieberman, PhD, of Boston Children's Hospital's Program in Cellular and Molecular Medicine reports "triple-negative" breast cancers may be vulnerable to drugs that attack ...
Aug 12, 2013
0
0
Researchers at The Pennsylvania State University College of Medicine, led by Dr. Ian S. Zagon, have discovered that a novel biological pathway, the OGF-OGFr axis, can be modulated in human triple-negative breast cancer cells ...
Aug 9, 2013
0
0
